Bradykinin stimulates eotaxin production by a human lung fibroblast cell line

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 1 I, 2000, Pages 117-123

  Sato, Etsuro ^a   Nelson, Dan K ^a   Koyama, Sekiya ^b   Hoyt, Jeffrey C ^a   Robbins, Richard A ^a,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Research Service   (United States)

Author keywords

Chemotaxis; Corticosteroids; Eosinophil

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; EOTAXIN; GLUCOCORTICOID; MESSENGER RNA; NEUTRALIZING ANTIBODY;

ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHILIA; FETUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG FIBROBLAST; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SUPERNATANT;

EID: 0033913189     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.107400     Document Type: Article

References (38)

1. Proud D, Kaplan AP. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol 1988;6:49-83.
2. Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983;72:1678-85.
3. Christiansen SC, Proud D, Cochrane CG. Detection of tissue kallikrein in the broncho alveolar lavage fluid of asthmatic subjects. J Clin Invest 1987;79:188-97.
4. Abraham WM, Burch RM, Farmer SG, Sielczak MW, Ahmed A, Cortes A. A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. Am Rev Respir Dis 1991;143:787-96.
5. Soler M, Sielczak M, Abraham WM. A bradykinin-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm Pharmacol 1990;3:9-15.
6. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
7. Smith H. Asthma, inflammation, eosinophils and bronchial hyperresponsiveness. Clin Exp Allergy 1992;22:187-97.
8. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994;6:865-73.
9. Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-7.
10. Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12.
11. Rothenberg ME, Luster AD, Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 1995;92:8960-4.
12. Gonzalo JA, Lloyd CM, Kremer L, et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996;98:2332-45.
13. Lamkhioued B, Renzi PM, Abi-Younes S, et al. Increased expression of eotaxin in broncho alveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-601.
14. Ying S, Robinson DS, Meng Q, et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997;27:3507-16.
15. Luster AD, Rothenberg ME. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol 1997;62:620-33.
16. Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-90.
17. Brown JR, Kleimberg J, Marini M, Sun G, Bellini A, Mattoli S. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and broncho alveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol 1998;114:137-46.
18. Teran LM, Mochizuki M, Bartels J, et al. Th1-and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20:777-86.
19. Miyamasu M, Nakajima T, Misaki Y, et al. Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation. Cytokine 1999;11:751-8.
20. Breul SD, Bradley KH, Hance AJ, Schafer MP, Berg RA, Crystal RG. Control of collagen production by human diploid lung fibroblasts. J Biol Chem 1980;255:5250-60.
21. Katayama K, Seyer JM, Raghow R, Kang AH. Regulation of extracellular matrix production by chemically synthesized subfragments of type I collagen carboxy propeptide. Biochemistry 1991;30:7097-104.
22. Chung KF, Patel HJ, Fadlon EJ, et al. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1β and TNFα effects of IL-10 and corticosteroids. Br J Pharmacol 1999;127:1145-50.
23. Lilly CM, Nakamura H, Kesselman H, et al. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest 1997;99:1767-73.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
25. Pan ZK, Zuraw BL, Lung CC, Prossnitz ER, Browning DD, Ye RD. Bradykinin stimulates NF-κB activation and interleukin 1beta gene expression in cultured human fibroblasts. J Clin Invest 1996;98:2042-9.
26. Hansel TT, De Vries IJ, Iff T, et al. An improved immune magnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-10.
27. Harvath L, Falk W, Leonard EJ. Rapid quanitification of neutrophil chemotaxis: use of polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J Immunol Methods 1980;37:39-45.
28. Marceau F. Kinin B1 receptors: a review. Immunopharmacology 1995;30:1-26.
29. Roisman GL, Lacronique JG, Des mazes-Dufeu N, Carre C, Le Cae A, Dusser DJ. Airway responsive ness to bradykinin is related to eosinophilic inflammation in asthma. Am J Respir Crit Care Med 1996;153:381-90.
30. Polosa R, Renaud L, Cacciola R, Prosperini G, Crimi N, Djukanovic R. Sputum eosinophilia is more closely associated with airway responsiveness to bradykinin than methacholine in asthma. Eur Respir J 1998;12:551-6.
31. Virchow JC Jr, Walker C, Hafner D, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995;151:960-8.
32. Azevedo I, de Blic J, Dumarey CH, Scheinmann P, Vargaftig BB, Bachelet M. Increased spontaneous release of tumour necrosis factor-alpha by alveolar macrophages from wheezy infants. Eur Respir J 1997;10:1767-73.
33. Koyama S, Sato E, Masubuchi T, et al. Human lung fibroblasts release chemokinetic activity for monocytes constitutively. Am J Physiol 1998;275:L223-30.
34. Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996;14:27-35.
35. Farmer SG, Burch RM, Meeker SA, Wilkins DE. Evidence for a pulmonary B3 bradykinin receptor. Mol Pharmacol 1989;36:1-8.
36. Farmer SG, Burch RM. Biochemical and molecular pharmacology of kinin receptors. Annu Rev Pharmacol Toxicol 1992;32:511-36.
37. Baenziger NL, Jong YJ, Yocum SA, et al. Diversity of B2 bradykinin receptors with nanomolar affinity expressed in passaged IMR90 human lung fibroblasts. Eur J Cell Biol 1992;58:71-80.
38. Sawutz DG, Faunce DM, Houck WT, Haycock D. Characterization of bradykinin B2 receptors on human IMR-90 lung fibroblasts: stimulation of 45Ca2+ efflux by D-Phe substituted bradykinin analogues. Eur J Pharmacol 1992;227:309-15.